Clinical Oncology - 2023;10(3)

Clinical Oncology

SEPTEMBER 15, 2023

[News from around the world]

[ ]

HUN 2023;10(3)

Clinical Oncology

SEPTEMBER 15, 2023

[Highlights of the 2023 Congress of the American Society of Clinical Oncology]

MÜHL Dorottya, NIKOLÉNYI Alíz, SÁNTHA Dóra, LENGYEL Zsuzsanna, ÁROKSZÁLLÁSI Anita, PÁPAI Zsuzsanna, HIDEGHÉTY Katalin, VIRGA József , VAJDICS Tímea, TÍMÁR József, PETÁK István, LAKATOS Gábor, ANDRÁS Csilla, TORDAY László, BÉGÁNYI Nóra, MOLDVAY Judit, OSTOROS Gyula, LENGYEL Erzsébet

[ ]

HUN 2023;10(3)

Clinical Oncology

SEPTEMBER 15, 2023

[Current treatment options in hormonsensitive metastatic prostate cancer – individualised prostate cancer therapy]

VAJDICS Tímea

[The incidence of prostate cancer shows an increasing trend worldwide, with > 1.2 million new cases of prostate cancer diagnosed annually.]

HUN 2023;10(3)

Clinical Oncology

SEPTEMBER 15, 2023

[Traditional and modern drug therapy options in the treatment of malignant primary bone tumors]

SZABÓ Ádám, ECKER Nóra, PÁPAI Zsuzsanna

[Primary malignant bone tumors are rare entities, accounting for only 0.2% of all malignant diseases.]

HUN 2023;10(3)

Clinical Oncology

SEPTEMBER 15, 2023

[Mortality due to cancer treatment delay: systematic review and meta-analysis]

TIMOTHY P Hanna, WILL D King, STEPHANE Thibodeau, MATTHEW Jalink, GREGORY A Paulin, ELIZABETH Harvey-Jones, DYLAN E O’Sullivan, CHRISTOPHER M Booth, RICHARD Sullivan, AJAY Aggarwal

[Objective: To quantify the association of cancer treatment delay and mortality for each four week increase in delay to inform cancer treatment pathways.]

HUN 2023;10(3)

Clinical Oncology

SEPTEMBER 15, 2023

[Molecular classification of prostate cancer and its clinical implications]

CSIZMARIK Anita, OLÁH Csilla, SOÓS Áron, NYIRÁDY Péter, SZARVAS Tibor

[The technical development of molecular investigation techniques has enabled the comprehensive discovery of the molecular background of prostate cancer.]

HUN 2023;10(3)

Clinical Oncology

SEPTEMBER 15, 2023

[New developments in cancer anorexia-cachexia syndrome]

HARISI Revekka

[Cancer anorexia-cachexia syndrome is a multi-organ syndrome with a complex set of symptoms and is a poor prognostic factor for patient survival.]

HUN 2023;10(3)

Clinical Oncology

SEPTEMBER 15, 2023

[The significance of BRCA1 and BRCA2 mutations as a risk factor in the development of solid tumors]

CSONKA Katalin, BAGHY Kornélia

[Mutations in BRCA1 and BRCA2 genes play a crucial role in the development of solid tumors, especially breast and ovarian cancer.]

HUN 2023;10(3)